HomeCompareESFS vs MRK

ESFS vs MRK: Dividend Comparison 2026

ESFS yields 400000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESFS wins by $5.011119029548644e+32M in total portfolio value
10 years
ESFS
ESFS
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full ESFS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ESFS vs MRK

📍 ESFS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESFSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESFS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESFS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESFS
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ESFS beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESFS + MRK for your $10,000?

ESFS: 50%MRK: 50%
100% MRK50/50100% ESFS
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ESFS
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESFS buys
0
MRK buys
0
No recent congressional trades found for ESFS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESFSMRK
Forward yield400000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5.011119029548644e+32M$56.8K
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$5.010957816668433e+32M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ESFS vs MRK ($10,000, DRIP)

YearESFS PortfolioESFS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,206$366.19+$40.00MESFS
2$149,615,521,729$149,572,710,280.37$12,650$502.35+$149615.51MESFS
3$522,880,052,725,200$522,719,964,116,949.25$14,407$694.19+$522880052.71MESFS
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$16,585$967.82+$1707862989289.03MESFS
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$19,342$1,363.89+$5213509402845684.00MESFS
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$22,913$1,947.19+$14874219058409543680.00MESFS
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$27,662$2,823.89+$3.966119623405075e+22MESFS
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$34,159$4,173.35+$9.88384363503273e+25MESFS
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$43,337$6,308.80+$2.302052364743449e+29MESFS
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$56,776$9,798.13+$5.011119029548644e+32MESFS

ESFS vs MRK: Complete Analysis 2026

ESFSStock

Eco Safe Systems USA, Inc. manufactures water treatment and water reclamation systems. It offers R-1000-HS Home Units for food and surface disinfection, and general cleanup in homes; R-1000 Restaurant Single Sink System for food and surface disinfection, and general cleanup in restaurants; R-1000-3S Restaurant Systems for restaurants or supermarkets; and MD-1500 System and MD-1500-C System to handle various departments of supermarkets or restaurants. The company also offers MD-2000 System for use on produce, meat, poultry, and seafood products to reduce bacteria counts, extend the shelf life, and reduce the risk of salmonella or any other bacteria or virus; and Ozone Hazmat Disinfection Systems for emergency first-responders to disinfect and decontaminate personnel and equipment after exposure to various biohazards and pathogens. In addition, it provides leasing services. The company serves various industries, including supermarkets, health care, food processing, restaurants, golf courses, laundry, animal care, and home system. Eco Safe Systems USA, Inc. was incorporated in 1998 and is headquartered in Tarzana, California.

Full ESFS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ESFS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESFS vs SCHDESFS vs JEPIESFS vs OESFS vs KOESFS vs MAINESFS vs JNJESFS vs ABBVESFS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.